X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3040) 3040
Publication (105) 105
Newsletter (92) 92
Book Review (52) 52
Magazine Article (26) 26
Book / eBook (25) 25
Conference Proceeding (5) 5
Reference (3) 3
Book Chapter (2) 2
Trade Publication Article (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2675) 2675
male (1883) 1883
female (1423) 1423
middle aged (1230) 1230
aged (1100) 1100
urination disorders - drug therapy (987) 987
urination disorders - etiology (969) 969
urology & nephrology (853) 853
adult (814) 814
index medicus (739) 739
urination disorders (498) 498
treatment outcome (470) 470
urination disorders - physiopathology (405) 405
aged, 80 and over (361) 361
animals (355) 355
prostatic hyperplasia - complications (352) 352
urination disorders - therapy (346) 346
urodynamics (330) 330
bladder (308) 308
urination (299) 299
prostatic hyperplasia - drug therapy (291) 291
quality of life (286) 286
child (281) 281
urination - drug effects (273) 273
adolescent (272) 272
care and treatment (263) 263
urinary incontinence (258) 258
urology (251) 251
urinary bladder - physiopathology (242) 242
overactive bladder (222) 222
urination disorders - diagnosis (222) 222
prospective studies (209) 209
double-blind method (208) 208
time factors (203) 203
adrenergic alpha-antagonists - therapeutic use (200) 200
benign prostatic hyperplasia (198) 198
follow-up studies (196) 196
urination - physiology (194) 194
rats (180) 180
risk factors (180) 180
medicine & public health (179) 179
drug therapy (168) 168
urinary bladder - drug effects (166) 166
urination disorders - chemically induced (166) 166
men (162) 162
prostate (162) 162
efficacy (160) 160
surveys and questionnaires (159) 159
women (159) 159
research (157) 157
child, preschool (150) 150
prevalence (150) 150
health aspects (148) 148
retrospective studies (145) 145
urinary incontinence - drug therapy (142) 142
incontinence (140) 140
analysis (138) 138
diagnosis (135) 135
urinary bladder (134) 134
medicine, general & internal (131) 131
urination disorders - complications (126) 126
management (123) 123
urine (123) 123
urodynamics - drug effects (122) 122
urination disorders - epidemiology (120) 120
quality-of-life (119) 119
urinary bladder - innervation (118) 118
lower urinary tract symptoms (117) 117
therapy (117) 117
dose-response relationship, drug (113) 113
surgery (112) 112
clinical neurology (111) 111
urinary bladder diseases - drug therapy (111) 111
severity of illness index (110) 110
symptoms (109) 109
pharmacology & pharmacy (106) 106
clinical trials as topic (105) 105
pediatrics (103) 103
urinary-tract symptoms (103) 103
drug administration schedule (102) 102
drug therapy, combination (101) 101
administration, oral (100) 100
urinary bladder, overactive - drug therapy (98) 98
muscarinic antagonists - therapeutic use (97) 97
nocturia (95) 95
oncology (95) 95
abridged index medicus (94) 94
desmopressin (92) 92
diagnosis, differential (92) 92
double-blind (91) 91
voiding dysfunction (87) 87
age factors (86) 86
children (86) 86
dysfunction (86) 86
neurosciences (86) 86
prostatic hyperplasia - physiopathology (86) 86
urinary bladder, overactive - physiopathology (86) 86
hypertrophy (85) 85
medical research (85) 85
urinary catheterization (85) 85
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2630) 2630
Japanese (133) 133
French (121) 121
German (117) 117
Russian (55) 55
Italian (38) 38
Spanish (31) 31
Danish (13) 13
Chinese (10) 10
Polish (9) 9
Dutch (8) 8
Hungarian (4) 4
Swedish (4) 4
Bulgarian (3) 3
Czech (3) 3
Hebrew (3) 3
Romanian (3) 3
Portuguese (2) 2
Bosnian (1) 1
Finnish (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
BMC Neuroscience, ISSN 1471-2202, 06/2016, Volume 17, Issue 1, p. 37
Background: Glucagon-like peptide 1 (GLP-1) analogs protect a variety of cell types against oxidative damage and vascular and neuronal injury via binding to... 
Oxidative stress | Pelvic nerve | Cerebral microcirculation | GLP-1 agonist | Middle cerebral artery occlusion | Voiding function | GLYCEMIC CONTROL | ACTIVATION | ISCHEMIA | BLOOD-BRAIN-BARRIER | NEUROSCIENCES | HYPERGLYCEMIA | GLUCAGON-LIKE PEPTIDE-1 | SIGNALING PATHWAY | NEURONAL NITRIC-OXIDE | RAT-BRAIN | PARKINSONS-DISEASE | Infarction, Middle Cerebral Artery - physiopathology | Diabetes Mellitus, Experimental - drug therapy | Cerebrovascular Circulation - physiology | Oxidative Stress - physiology | Urination Disorders - physiopathology | Male | Glucagon-Like Peptide-1 Receptor - metabolism | Infarction, Middle Cerebral Artery - complications | Liraglutide - pharmacology | Protective Agents - pharmacology | Cognition Disorders - etiology | Diabetes Mellitus, Experimental - complications | Infarction, Middle Cerebral Artery - drug therapy | Diabetes Mellitus, Experimental - physiopathology | Cognition Disorders - physiopathology | Cerebrovascular Circulation - drug effects | Urination Disorders - drug therapy | Cognition Disorders - drug therapy | Hypoglycemic Agents - pharmacology | Peptides - pharmacology | Animals | Movement Disorders - physiopathology | Movement Disorders - etiology | Urination Disorders - etiology | Mice | Venoms - pharmacology | Oxidative Stress - drug effects | Glucagon-Like Peptide-1 Receptor - agonists | Nootropic Agents - pharmacology | Movement Disorders - drug therapy | Prevention | Brain damage | Cognition | Research
Journal Article
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 3, pp. 398 - 407
Abstract Background Storage symptoms are often undertreated in men with lower urinary tract symptoms (LUTS). Objective To evaluate the combination of an... 
Urology | Storage symptoms | Overactive bladder | Voiding symptoms | Solifenacin | Tamsulosin OCAS | Lower urinary tract symptoms | OCAS | Tamsulosin | TRIAL | URGENCY | PERCEPTION | UROLOGY & NEPHROLOGY | BLADDER OUTLET OBSTRUCTION | RELIABILITY | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Solifenacin Succinate | Urination Disorders - physiopathology | Urodynamics - drug effects | Male | Quinuclidines - administration & dosage | Adrenergic alpha-1 Receptor Antagonists - administration & dosage | Dose-Response Relationship, Drug | Drug Dosage Calculations | Urological Agents - adverse effects | Lower Urinary Tract Symptoms - drug therapy | Time Factors | Urination - drug effects | Adrenergic alpha-1 Receptor Antagonists - adverse effects | Urological Agents - administration & dosage | Drug Therapy, Combination | Quinuclidines - adverse effects | Urination Disorders - diagnosis | Double-Blind Method | Europe | Urination Disorders - drug therapy | Lower Urinary Tract Symptoms - physiopathology | Treatment Outcome | Tetrahydroisoquinolines - administration & dosage | Tetrahydroisoquinolines - adverse effects | Muscarinic Antagonists - administration & dosage | Lower Urinary Tract Symptoms - diagnosis | Quality of Life | Sulfonamides - adverse effects | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Sulfonamides - administration & dosage | Tamsulosin hydrochloride
Journal Article
Journal Article